Search
Nefopam
go.drugbank.com/drugs/DB12293ApprovedInvestigationalWithdrawnNefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.
Categories: Analgesics, Non-NarcoticProducts: ACUPAN SOLUTION FOR INJECTION 20MG/2MLIsavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigationalIsavuconazonium is a second-generation triazole antifungal approved on March 6, 2015 by the FDA and July 2015 by the EMA for the treatment of adults with invasive aspergillosis and invasive mucormycosis … , marketed by Astellas under the brand Cresemba.
Categories: Isavuconazole and ProdrugsProducts: Cresemba 100mg Capsule, CRESEMBA CAPSULES 100MGAtovaquone
go.drugbank.com/drugs/DB01117ApprovedInvestigationalAtovaquone is a hydroxynaphthoquinone, or an analog of ubiquinone, that has antimicrobial and antipneumocystis activity. It is being used in antimalarial protocols.
Mixtures: Atovaquone and Proguanil HCl, Atovaquone and Proguanil HClCategories: proguanil and atovaquone, Antiparasitic Products, Insecticides and RepellentsTerfenadine
go.drugbank.com/drugs/DB00342ApprovedInvestigationalWithdrawnIn the U.S., Terfenadine was superseded by fexofenadine in the 1990s due to the risk of cardiac arrhythmia caused by QT interval prolongation.
Categories: Histamine H1 Antagonists, Non-SedatingProducts: Seldane Tab 120mg, Apo-terfenadine Tab 120mgTrovafloxacin
go.drugbank.com/drugs/DB00685ApprovedWithdrawnIt exerts its antibacterial activity by inhibiting the uncoiling of supercoiled DNA in various bacteria by blocking the activity of DNA gyrase and topoisomerase IV. … Trovafloxacin is a broad spectrum antibiotic that has been commonly marketed under the brand name Trovan by Pfizer.
Products: Trovan Tablets 100mgIbrutinib
go.drugbank.com/drugs/DB09053ApprovedInvestigational[L45894] Ibrutinib was approved by the EMA in October 2014 [L45884] and by Health Canada in November 2014. … [A32299] Ibrutinib was developed by Pharmacyclics Inc and was first approved by the FDA in November 2013 for the treatment of mantle cell lymphoma (MCL) under accelerated approval;[L12228] however, in
Categories: Antineoplastic and Immunomodulating AgentsProducts: IMBRUVICA CAPSULE 140MG, IMBRUVICA® CAPSULAS 140MGBurosumab
go.drugbank.com/drugs/DB14012ApprovedInvestigationalThis is the first drug approved to treat adults and children ages 1 year and older with X-linked hypophosphatemia (XLH), which is a rare, inherited form of rickets. … It causes impaired bone growth and development in children and adolescents and issues with bone mineralization throughout a patient’s life [L2346].
Categories: Amino Acids, Peptides, and Proteins, Drugs Affecting Bone Structure and MineralizationProducts: CRYSVITA ® SOLUCION PARA INYECCIÓN 10MG/MLLoxoprofen
go.drugbank.com/drugs/DB09212ApprovedInvestigationalIt is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina. … Loxoprofen is a propionic acid derivative non-steroidal anti-inflammatory drug.
Categories: Antiinflammatory and Antirheumatic Products, Non-Steroids, Antiinflammatory and Antirheumatic ProductsProducts: LOXOTOP PAP 100mg PatchNelfinavir
go.drugbank.com/drugs/DB00220ApprovedInvestigationalIt is used in combination with other antiviral drugs in the treatment of HIV in both adults and children.
Products: Viracept -250mg, Viracept -50mgEltrombopag
go.drugbank.com/drugs/DB06210ApprovedInvestigationalITP is a condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood. … Eltrombopag has also been recently approved (late 2012) for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based
Categories: Blood and Blood Forming OrgansProducts: Revolade Tablet 25mg, REVOLADE FILM-COATED TABLET 25MG